Annual ROE
-69.76%
-15.10%-27.63%
December 31, 2023
Summary
- As of February 10, 2025, NGM annual return on equity is -69.76%, with the most recent change of -15.10% (-27.63%) on December 31, 2023.
- During the last 3 years, NGM annual ROE has fallen by -36.20% (-107.87%).
Performance
NGM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-71.83%
-4.85%-7.24%
December 31, 2023
Summary
- As of February 10, 2025, NGM quarterly return on equity is -71.83%, with the most recent change of -4.85% (-7.24%) on December 31, 2023.
- Over the past year, NGM quarterly ROE has dropped by -6.90% (-10.63%).
Performance
NGM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NGM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.6% | -10.6% |
| 3 y3 years | -107.9% | -111.3% |
| 5 y5 years | -10000.0% | -10000.0% |
NGM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +78.5% | at low | +108.0% | at low |
| 5 y | 5-year | +107.9% | at low | +228.3% | at low |
| alltime | all time | -696.2% | at low | -699.1% | at low |
NGM Biopharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -69.76%(+27.6%) | -71.83%(+7.2%) |
| Sep 2023 | - | -66.98%(-1.2%) |
| Jun 2023 | - | -67.81%(+4.4%) |
| Mar 2023 | - | -64.93%(+18.5%) |
| Dec 2022 | -54.66%(+39.8%) | -54.80%(+12.8%) |
| Sep 2022 | - | -48.60%(+19.9%) |
| Jun 2022 | - | -40.54%(+14.8%) |
| Mar 2022 | - | -35.31%(+2.3%) |
| Dec 2021 | -39.09%(+16.5%) | -34.53%(-4.0%) |
| Sep 2021 | - | -35.97%(-3.8%) |
| Jun 2021 | - | -37.41%(+6.3%) |
| Mar 2021 | - | -35.18%(+3.5%) |
| Dec 2020 | -33.56% | -33.99%(+17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -28.86%(+31.9%) |
| Jun 2020 | - | -21.88%(-0.8%) |
| Mar 2020 | - | -22.06%(-18.7%) |
| Dec 2019 | -38.46%(-8460.9%) | -27.13%(+43.0%) |
| Sep 2019 | - | -18.97%(-19.2%) |
| Jun 2019 | - | -23.47%(-669.7%) |
| Mar 2019 | - | 4.12%(+858.1%) |
| Dec 2018 | 0.46%(-96.1%) | 0.43%(-96.4%) |
| Sep 2018 | - | 11.99%(+105.3%) |
| Jun 2018 | - | 5.84%(+79.1%) |
| Mar 2018 | - | 3.26% |
| Dec 2017 | 11.70%(+94.4%) | - |
| Dec 2016 | 6.02% | - |
FAQ
- What is NGM Biopharmaceuticals annual return on equity?
- What is the all time high annual ROE for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual ROE year-on-year change?
- What is NGM Biopharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly ROE year-on-year change?
What is NGM Biopharmaceuticals annual return on equity?
The current annual ROE of NGM is -69.76%
What is the all time high annual ROE for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual return on equity is 11.70%
What is NGM Biopharmaceuticals annual ROE year-on-year change?
Over the past year, NGM annual return on equity has changed by -15.10% (-27.63%)
What is NGM Biopharmaceuticals quarterly return on equity?
The current quarterly ROE of NGM is -71.83%
What is the all time high quarterly ROE for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly return on equity is 11.99%
What is NGM Biopharmaceuticals quarterly ROE year-on-year change?
Over the past year, NGM quarterly return on equity has changed by -6.90% (-10.63%)